Chemical Structure (Zilretta 01)
Zilretta Kit
Product Images NDC 65250-003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Zilretta (NDC 65250-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pacira Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Zilretta 02)
The text describes a graph or a table with data related to ADP (Average Daily Pain) on a scale of 0 to 10. The data shows the LS Mean Change from Baseline for three groups - Zilretta, Placebo, and Active control (immediate-release tramcinolone acetonide) over 12 weeks post-treatment. The primary endpoint was measured in weeks post-treatment, and there is a secondary exploratory endpoint.*
Figure 1 (Zilretta 03)
Figure 2 (Zilretta 04)
Figure 3 (Zilretta 05)
Figure 4 (Zilretta 06)
Figure 5 (Zilretta 07)
Figure 6 (Zilretta 08)
ZILRETTIA is a medication that comes in a powder vial with an adapter in place.*
Figure 7 (Zilretta 09)
Figure 8 (Zilretta 10)
ZILRETTA is a type of medication that is delivered in powder form and housed in a vial. Additional information is not available from the provided text.*
Figure 9 (Zilretta 11)
ZIRETTA is a product that comes in the form of a powder vial. Unfortunately, it is not clear what this product is used for or what its benefits are without further context.*
Figure 10 (Zilretta 12)
Figure 11 (Zilretta 13)
This text describes a comparison between something that is incorrect and something that is correct. It does not provide any additional information beyond that.*
Figure 12 (Zilretta 14)
Figure 13 (Zilretta 15)
Figure 14 (Zilretta 16)
Principal Display Panel (Kit Carton)
This is a description of a prescription drug called Zilretta with the active ingredient Triamcinolone Acetonide. It is for intra-articular injection only and comes in a single-dose kit with a sterile vial adapter. After reconstitution, each dose delivers 32 mg of the drug. The drug should be kept out of reach of children and is not for intravenous, intradermal, intramuscular, intraocular, epidural, subcutaneous, or intrathecal use. The package insert should be referred to for dosage and administration information. Zilretta can be stored at 20-25°C for up to six weeks.*
Principal Display Panel (32 mg Vial Label)
Number and Expiration Date not-available.
This is a description for the medication Zilretta. It comes in a single-use vial, and any unused portion must be discarded. Dosage and administration information is provided in the package insert. It should be refrigerated at 2-8°C or stored at 20-25°C for up to 6 weeks. This medication is intended for intra-articular injection only and must be reconstituted. The manufacturer is Pacira Pharmaceuticals, Inc. based in San Diego, California. The NDC code for this medication is 65250-001-01 and it is only available with a prescription.*
Principal Display Panel (5 mL Vial Label)
This is a description of a 5mL vial of diluent solution for use with Zilretta medication. The solution contains 0.9% (w/w) sodium chloride, 0.5% (w/w) sodium carboxymethylcellulose, and 0.1% (w/w) polysorbate-80. It is a sterile, single-use vial that should not be administered directly and should be stored between 2-25°C (36-77°F). The manufacturer is Pacira Pharmaceuticals. Lot number information is cut off.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
